A Study to Evaluate Oral Salmon Calcitonin in the Treatment of Osteoporosis in Postmenopausal Women Taking Calcium and Vitamin D

PHASE3CompletedINTERVENTIONAL
Enrollment

4,665

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

August 31, 2011

Study Completion Date

November 30, 2011

Conditions
Osteoporosis
Interventions
DRUG

SMC021 Oral calcitonin

0.8mg SMC021 - oral calcitonin, once daily

DRUG

SMC021 Placebo

SMC021 - Placebo, once daily

Trial Locations (16)

2750

CCBR Ballerup, Ballerup Municipality

7100

CCBR Vejle, Vejle

9000

CCBR Aalborg, Aalborg

10128

CCBR Estonia, Tallinn

10323

CCBR Lithuania, Vilnius

30501

United Osteporosis Centers, Gainesville

48236

Michigan Bone & Mineral Clinic PC,, Detroit

53002

CCBR Czech, Pardubice

69437

Hopital Edouard Herriot, Lyon

97213

Oregon Osteoporosis Center, Portland

102206

CCBR China, Beijing

22271-100

CCBR Brazil, Rio de Janeiro

Unknown

CCBR Hong Kong, Hong Kong

Department of Internal Medicine, University of Florence, Florence

04703

CCBR Poland, Warsaw

030463

CCBR Romania, Bucharest

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

lead

Nordic Bioscience A/S

INDUSTRY